Role of Laghumanjisthadi Ghana and Raktamokshan in Gout.
- Conditions
- Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system
- Registration Number
- CTRI/2024/08/071793
- Lead Sponsor
- Dr Pranoti Tukaram Khandekar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients having clinical signs and symptoms of vatrakta with special reference to gout like Sandhi toda(jiont pricking pain),Sandhi daha(burning sensation),Sparshasahatva(Tenderness),Sandhi shotha (swelling),Raga (redness or discolouration of joint)described in aaaaaaaaayurvedic classics without any bar of caste ,sex,religion .
2 Patient having serum uric acid level above 6
1 Patients having chronicity of vatrakta more than 5 years
2 Patients on Anti platelet aggregation drugs
3 Patients on anti coagulant drugs
4 Patients having bleeding disorders
5 Patients contraindicated for for Raktamokshana
6 Pregnant and Lactating mothers
7 Patients with illness like HIV, Malignancy,Cardiac disease ,Major Liver Disorders ,Uncontrolled Hypertension , End stage Renal disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To Evaluate the efficacy Hypourecemic effect of Laghumanjisthadi Ghana and Raktamokshan in the management of Vatarakta.Timepoint: 21 days
- Secondary Outcome Measures
Name Time Method 1 To evaluate the Hypourecemic effect of Laghumanjisthadi Ghana & Raktamokshan in Vatarakta. <br/ ><br>2.To study adverse effect of Laghumanjisthadi Ghana if any <br/ ><br> 3 To study adverse effect of Raktamokshan if any <br/ ><br>4.To study etiopathology of Vatarakta.Timepoint: 21 days